You are here

A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Diabetes Mellitus, Diabetic Retinopathy
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- diabetic patients, either man or woman, with diabetic retinopathy, at least 18 years
of age

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- patients treated with laser therapy within the last 90 days

- patients with likelyhood to require cataract surgery within 3 months

- Uncontrolled diabetes

NCT00457470
Pfizer
Withdrawn
A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Type 2 Diabetes Mellitus
NCT02292433
All Genders
20+
Years
Hachioji-shi, Tokyo
Type 1 Diabetes Mellitus
NCT00424437
All Genders
12+
Years
Multiple Sites
Type 2 Diabetes Mellitus
NCT00367445
All Genders
18+
Years
Chula Vista, California

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now